Ryan Specialty (RYAN) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Ryan Specialty (NYSE: RYAN):

• 7/13/2026 – Ryan Specialty had its price target raised by JPMorgan Chase & Co. from $37.00 to $39.00. They now have an “underweight” rating on the stock.
• 7/9/2026 – Ryan Specialty had its price target raised by Cantor Fitzgerald from $33.00 to $34.00. They now have a “neutral” rating on the stock.
• 7/9/2026 – Ryan Specialty had its price target raised by Cantor Fitzgerald from $33.00 to $34.00. They now have a “neutral” rating on the stock.
• 7/9/2026 – Ryan Specialty had its price target raised by Wells Fargo & Company from $31.00 to $39.00. They now have an “equal weight” rating on the stock.
• 7/9/2026 – Ryan Specialty had its price target raised by Mizuho from $35.00 to $39.00. They now have a “neutral” rating on the stock.
• 7/9/2026 – Ryan Specialty was downgraded by Wolfe Research from “outperform” to “peer perform”.
• 7/8/2026 – Ryan Specialty had its price target lowered by UBS Group AG from $52.00 to $50.00. They now have a “buy” rating on the stock.
• 7/8/2026 – Ryan Specialty had its price target raised by Keefe, Bruyette & Woods from $44.00 to $48.00. They now have an “outperform” rating on the stock.
• 7/7/2026 – Ryan Specialty had its price target raised by Barclays PLC from $39.00 to $46.00. They now have an “overweight” rating on the stock.
• 7/6/2026 – Ryan Specialty had its price target raised by Morgan Stanley from $39.00 to $42.00. They now have an “overweight” rating on the stock.
• 7/1/2026 – Ryan Specialty had its price target raised by The Goldman Sachs Group, Inc. from $35.00 to $40.00. They now have a “neutral” rating on the stock.
• 6/30/2026 – Ryan Specialty was upgraded by Zacks Research from “strong sell” to “hold”.
• 6/9/2026 – Ryan Specialty had its price target raised by UBS Group AG from $51.00 to $52.00. They now have a “buy” rating on the stock.
• 6/8/2026 – Ryan Specialty was downgraded by The Goldman Sachs Group, Inc. from “buy” to “neutral”. They now have a $35.00 price target on the stock, down from $42.00.
• 5/26/2026 – Ryan Specialty had its “outperform” rating reaffirmed by Keefe, Bruyette & Woods.
• 5/21/2026 – Ryan Specialty was given a new $39.00 price target by UBS Group AG.
• 5/21/2026 – Ryan Specialty had its price target lowered by Morgan Stanley from $45.00 to $39.00. They now have an “overweight” rating on the stock.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 26th. Investors of record on Tuesday, May 12th were issued a dividend of $0.13 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a yield of 1.3%. Ryan Specialty’s dividend payout ratio is 67.53%.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Chairman Patrick G. Ryan acquired 120,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $32.50 per share, with a total value of $3,900,000.00. Following the completion of the acquisition, the chairman owned 13,817,859 shares of the company’s stock, valued at $449,080,417.50. This trade represents a 0.88% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John W. Rogers, Jr. purchased 7,500 shares of the business’s stock in a transaction on Wednesday, June 10th. The stock was bought at an average cost of $35.16 per share, with a total value of $263,700.00. Following the purchase, the director owned 117,933 shares in the company, valued at approximately $4,146,524.28. This represents a 6.79% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders have bought 130,715 shares of company stock valued at $4,263,590. 52.03% of the stock is currently owned by corporate insiders.

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.